C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

Running, not enrolling · Phase 3

Conditions studied: HEPATITIS C VIRUS CHRONIC INFECTION

In brief

The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.

Key facts

Study ID
NCT06868264
Run by
Atea Pharmaceuticals, Inc.
People needed
880
Starts
2025-04-07
Expected to finish
2026-12-01
Last updated by the study team
2025-12-05

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.